Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Primary Breast Cancer × Iodine-123 × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Thyroid Neoplasms 2 Neuroendocrine Tumors 2 Primary Breast Cancer 1 Parkinson Disease 1 Malignancy of Thyroid Nodules 1 Adenocarcinoma, Follicular 1

Interventions

Docetaxel 4 Epirubicin 3 Cyclophosphamide 3 Paclitaxel 2 Vinorelbine 1 Tamoxifen 1 Iodine-123 1 Fluorouracil 1 Doxorubicin 1 Carboplatin 1 CP protocol 1 Anthracyclines 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05923177 2025-04-09

Molecular Imaging of HER2 Expression in Breast Cancer Using [123I] I-(HE)3-G3

Tomsk National Research Medical Center of the Russian Academy of Sciences

Phase 1 Completed

Primary Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡